Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices.
Business, legal identity, ownership structure and classifications.
What the company does
About
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
Sector and industry values retain their source labels. A classification provider, taxonomy version and assignment date are not established unless the cited record states them.
Stable business record
Identity and status
Ownership and listing state
Public listing published
Ownership not asserted
The canonical public record includes at least one active security listing.
Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
S&P 500S&P Dow Jones Indices · NYSE: LHcurrentEvidence
Board leadership, management, committees and their disclosed responsibilities.
Committee appointments
Structured records are unavailable. This does not establish that no records exist.
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Sep 24, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Only current, confirmed leadership roles with public evidence are included in the canonical projection.
Record
Status
Authority
Effective
Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
Financials & Filings
Reported statements, original filings and proxy disclosures with their reporting periods.
Financial statements
Structured records are unavailable. This does not establish that no records exist.
Filing library
Structured records are unavailable. This does not establish that no records exist.
Proxy & Voting
Structured records are unavailable. This does not establish that no records exist.
Ownership & Markets
Ownership, funding and dated financial information.
Ownership, control and market context
Structured records are unavailable. This does not establish that no records exist.
Ownership disclosures retain their reporting dates and source types. Economic ownership, investment discretion and voting authority are distinct. Activism and settlement-dated short interest are not established by holdings or short-sale volume.
Risk & Assurance
Disclosed coverage, ratings and assurance scope.
Disclosures and oversight
Structured records are unavailable. This does not establish that no records exist.
Credit-rating evidence, where published, appears in the Governance and Basis sections with its source and reporting date. Insurance coverage, cyber ratings and assurance reports require their own issuer, scope, date and usage rights. Indemnification does not establish insurance coverage.
Legal and regulatory records
Company-specific matters
Structured records are unavailable. This does not establish that no records exist.
Relevant governance developments
Structured records are unavailable. This does not establish that no records exist.
5 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
other · Source published: May 4, 2026 · Retrieved: May 4, 2026
Supports 13 claims
Leadership Role: Akinbolade Oyegunwa: Executive Vice President and Chief Information & Technology Officer · Claim reviewed: Sep 24, 2026
Leadership Role: Amy Summy: EVP, Chief Marketing Officer & Consumer Health Lead · Claim reviewed: Sep 24, 2026
Leadership Role: Anita Z. Graham: Executive Vice President & Chief Human Resources Officer · Claim reviewed: Sep 24, 2026
Leadership Role: Brian J. Caveney: EVice President, President of Early Development Research Laboratories and Chief Medical & Scientific Officer · Claim reviewed: Sep 24, 2026
Leadership Role: Bryan T. Vaughn: Executive Vice President of Diagnostics · Claim reviewed: Sep 24, 2026
Leadership Role: Christin O'Donnell: Vice President of Investor Relations · Claim reviewed: Sep 24, 2026
Leadership Role: Jonathan C. Meltzer: Executive Vice President of Operations · Claim reviewed: Sep 24, 2026
Leadership Role: Julia Wang: Chief Financial Officer & Executive Vice President · Claim reviewed: Sep 24, 2026